Lv3
202 积分 2021-12-23 加入
Perioperative ctDNA-Based MRD Detection in NSCLC— Letter
7小时前
已完结
Opportunities and challenges of neoadjuvant targeted therapy in nonsmall cell lung cancer
8小时前
已完结
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
8小时前
已完结
In an Era of ctDNA, Is Metabolomics the New Kid on the Block?
10小时前
已完结
Advances in liquid biopsy–based markers in NSCLC
10小时前
已完结
Exploring multidimensional cfDNA methylation fragmentomics for non-invasive postoperative assessment in early-stage lung cancer
10小时前
已关闭
Potential of Minimal Residual Disease in Guiding Adjuvant Therapy Decisions in Non–Small Cell Lung Cancer
10小时前
已完结
Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers
10小时前
已完结
Perioperative immunotherapy for nonsmall cell lung cancer
11小时前
已关闭
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
11小时前
已完结
皖公网安备34019202002308
